Cargando…
The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy
Several chronic neuroinflammatory diseases, including Parkinson’s disease (PD), have the so-called ‘redox imbalance’ in common, a dynamic system modulated by various factors. Among them, alteration of the mitochondrial functionality can cause overproduction of reactive oxygen species (ROS) with the...
Autores principales: | Travaglione, Sara, Loizzo, Stefano, Vona, Rosa, Ballan, Giulia, Rivabene, Roberto, Giordani, Danila, Guidotti, Marco, Dupuis, Maria Luisa, Maroccia, Zaira, Baiula, Monica, Rimondini, Roberto, Campana, Gabriele, Fiorentini, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247702/ https://www.ncbi.nlm.nih.gov/pubmed/32403292 http://dx.doi.org/10.3390/ijms21093390 |
Ejemplares similares
-
The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study
por: Fabbri, Alessia, et al.
Publicado: (2018) -
The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases
por: Travaglione, Sara, et al.
Publicado: (2014) -
CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease
por: Loizzo, Stefano, et al.
Publicado: (2013) -
Correction: CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease
por: Loizzo, Stefano, et al.
Publicado: (2013) -
CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice
por: Travaglione, Sara, et al.
Publicado: (2015)